Jumping directly to a higher dose can cause severe nausea, vomiting, and discomfort
Appetite, weight, glucose, and other metabolic markers may change after stopping incretin-based treatment, but retatrutide-specific stopping patterns need more evidence
Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture
This varies by medication and by individual, so it's important to keep an eye on your own behavior and your target goals, and discuss anything concerning with your doctor
The mechanisms could include reduced inflammation, improved metabolic health, direct effects on brain reward pathways, or the psychological benefit of successful weight management